Approval · Notice of Compliance 15028 · 2013
SOVALDI: Notice of Compliance 15028
Issued December 13, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15028
- Date
- December 13, 2013
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOVALDI | 02418355 | Marketed |
Medicinal ingredients
- SOFOSBUVIR 400 MG per TAB